PATENT CLAIM ANALYSIS

Application Number: 16201205
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "470000"]

Abstract:
The present invention targets the Zika virus and other disease-causing microbes including viruses, bacteria, fungi, and parasites. It does this using agents and methods with little toxicity compared to existing therapies.

Claim (Index 14):
The method of  claim 13 , wherein the viral infection is selected from the group consisting of Zika virus, Norovirus, Respiratory Syncytial Virus, Influenza, Adenovirus 5, HPV 11, Lassa Fever virus, Powassan virus, Rift Valley virus, and combinations thereof.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 98.0
- Lexical Diversity: 1.16129
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15825982', '14855744', '15370680', '15222062', '12797575']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7695838672676091
- 35 USC 102 Novelty (BERT): 0.501105962689036
- Combined Prediction Score: 0.7427360768097517
- Mean Citation Score: 206.917952
- Max Citation Score: 231.83357
- Similarity Product: 158.17275594795882

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test